BL-B01D1 Phase 1 clinical data from ASCO 2023: commentary by oncologists featured on OncLive

Chicago, Illinois
June 8st, 2023

Pasi A. Jänne, M.D., Ph.D., director, Lowe Center for Thoracic Oncology, director, Belfer Center for Applied Cancer Science, director, Chen-Huang Center for EGFR Mutant Lung Cancers, senior physician, Dana-Farber Cancer Institute; professor, medicine, Harvard Medical School.

Helena A. Yu, M.D., associate attending physician, Memorial Sloan Kettering Cancer Center.

Melissa L. Johnson, M.D., director, Lung Cancer Research, Sarah Cannon Research Institute; chair, Oncology Department, member, Medical Executive Committee, TriStar Centennial Medical Center.
Pipeline News Careers Contact Terms of Use
© 2024 SystImmune, Inc. All rights reserved.